Search Results - "Kalinou, C."

A real‐world, non‐interventional, prospective study of the effectiveness and safety of apremilast in bio‐naïve adults with moderate plaque psoriasis treated in the routine care in Greece – the ‘APRAISAL’ study by Ioannides, D., Antonakopoulos, N., Chasapi, V., Oikonomou, C., Tampouratzi, E., Lazaridou, E., Rigopoulos, D., Neofotistou, O., Drosos, A., Anastasiadis, G., Rovithi, E., Kalinou, C., Papadavid, E., Aronis, P., Papageorgiou, M., Protopapa, A., Bassukas, I., Lefaki, I., Zafiriou, E., Krasagakis, K., Pokas, E., Anagnostopoulos, Z., Kekki, A., Papakonstantis, M.

“…Background Real‐world data in patients with moderate psoriasis treated with apremilast is limited. Objectives To evaluate the effectiveness and safety of…”
Get full text

POSB63 Analysis of Cost per PASI75 and per Dlqi 0/1 Responder over 52 WEEKS in Patients with Moderate Plaque Psoriasis Initiated on Apremilast, Remaining on Apremilast or Switching to Biologics, and Patients Hypothetically Treated with Biologics AB Initio, Based on the Results of the Apraisal Multicenter Observational Study in Greece by Sotiriou, E, Chasapi, V, Gialeli, E, Katsantonis, J, Lazaridou, E, Rompoti, N, Neofotistou, O, Drosos, A, Tomai, KD, Rovithi, E, Kalinou, C, Papadavid, E, Aronis, P, Papageorgiou, M, Protopapa, A, Mavridou, K, Lefaki, I, Zafiriou, E, Krasagakis, K, Pokas, E, Kekki, A, Anagnostopoulos, Z, Antonakopoulos, N, Papakonstantis, M

Get full text